Achieve Life Sciences Inc (ACHV)
NASDAQ:ACHV
Total Valuation
Achieve Life Sciences has a market cap or net worth of $171.97M. The enterprise value is $165.99M.
Market Cap$171.97M
Enterprise Value$165.99M
Share Statistics
Achieve Life Sciences has 53,239,986 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding53,239,986
Owned by Insiders1.68%
Owned by Institutions13.12%
Financial Efficiency
Achieve Life Sciences’s return on equity (ROE) is -2.54 and return on invested capital (ROIC) is -150.47%.
Return on Equity (ROE)-2.54
Return on Assets (ROA)-1.31
Return on Invested Capital (ROIC)-150.47%
Return on Capital Employed (ROCE)-1.68
Revenue Per Employee0.00
Profits Per Employee-2.19M
Employee Count25
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Achieve Life Sciences is ―. Achieve Life Sciences’s PEG ratio is -4.92.
PE Ratio―
PS Ratio0.00
PB Ratio10.07
Price to Fair Value10.07
Price to FCF-4.38
Price to Operating Cash Flow-3.48
PEG Ratio-4.92
Income Statement
In the last 12 months, Achieve Life Sciences had revenue of 0.00 and earned -54.65M in profits. Earnings per share was -1.25.
Revenue0.00
Gross Profit-228.00K
Operating Income-54.88M
Pretax Income-54.65M
Net Income-54.65M
EBITDA-54.65M
Earnings Per Share (EPS)-1.25
Cash Flow
In the last 12 months, operating cash flow was -49.47M and capital expenditures -3.00K, giving a free cash flow of -49.47M billion.
Operating Cash Flow-49.47M
Free Cash Flow-49.47M
Free Cash Flow per Share-0.93
Dividends & Yields
Achieve Life Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.09
52-Week Price Change33.47%
50-Day Moving Average4.18
200-Day Moving Average3.80
Relative Strength Index (RSI)37.42
Average Volume (3m)637.82K
Important Dates
Achieve Life Sciences upcoming earnings date is May 7, 2026, After Close (Confirmed).
Last Earnings DateMar 24, 2026
Next Earnings DateMay 7, 2026
Ex-Dividend Date―
Financial Position
Achieve Life Sciences as a current ratio of 4.39, with Debt / Equity ratio of 69.50%
Current Ratio4.39
Quick Ratio4.39
Debt to Market Cap0.07
Net Debt to EBITDA0.11
Interest Coverage Ratio-67.01
Taxes
In the past 12 months, Achieve Life Sciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Achieve Life Sciences EV to EBITDA ratio is -3.86, with an EV/FCF ratio of -4.26.
EV to Sales0.00
EV to EBITDA-3.86
EV to Free Cash Flow-4.26
EV to Operating Cash Flow-4.26
Balance Sheet
Achieve Life Sciences has $36.40M in cash and marketable securities with $14.96M in debt, giving a net cash position of $21.45M billion.
Cash & Marketable Securities$36.40M
Total Debt$14.96M
Net Cash$21.45M
Net Cash Per Share$0.40
Tangible Book Value Per Share$0.45
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Achieve Life Sciences is $14.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$14.00
Price Target Upside333.44% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast―
EPS Growth Forecast-22.06%